Structure Therapeutics (GPCR) Capital Expenditures (2022 - 2026)
Quarterly Capital Expenditures rose 276.43% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, up 22.19% year-over-year, with the annual reading at $894000.0 for FY2025, 30.7% down from the prior year.
Structure Therapeutics' Capital Expenditures history spans 5 years, with the latest figure at $1.2 million for Q1 2026.
- Capital Expenditures came in at $1.2 million for Q1 2026, up from -$1.2 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $1.9 million in Q4 2023 to a low of -$1.2 million in Q4 2025.
- The 5-year median for Capital Expenditures is $162000.0 (2024), against an average of $366466.7.
- Year-over-year, Capital Expenditures skyrocketed 2512.68% in 2023 and then crashed 7750.0% in 2025.
- Structure Therapeutics' Capital Expenditures stood at $71000.0 in 2022, then surged by 2512.68% to $1.9 million in 2023, then crashed by 99.14% to $16000.0 in 2024, then plummeted by 7750.0% to -$1.2 million in 2025, then surged by 196.57% to $1.2 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Capital Expenditures are $1.2 million (Q1 2026), -$1.2 million (Q4 2025), and $1.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 230.60 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 232,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Mar 31, 2025 | 314,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Sep 30, 2024 | 685,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 427,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | 1.86 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 121,000.00 |
| Sep 30, 2023 | 121,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 72,000.00 |
| Sep 30, 2022 | 72,000.00 |
| Jun 30, 2022 | -53,000.00 |
| Jun 30, 2022 | -53,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Mar 31, 2022 | 65,000.00 |